Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids

Significance Desorption electrospray ionization mass spectrometry imaging (DESI-MSI) is a label-free molecular imaging technique that provides a window into the biochemical processes present in benign and malignant prostate tissue. This is important both in improving the understanding of tissue biology and in achieving rapid cancer diagnosis. We applied DESI-MSI to record lipid, carbohydrate, and most importantly, small metabolite images from 54 normal and malignant prostate tissue specimens. Several Krebs cycle intermediates were present at different concentrations in prostate cancer compared with normal tissue. Statistical calculations identified panels of metabolites that could readily distinguish prostate cancer from normal tissue with nearly 90% accuracy in a validation set. The results also indicated that the ratio of glucose to citrate ion signals could be used to accurately identify prostate cancer. Accurate identification of prostate cancer in frozen sections at the time of surgery can be challenging, limiting the surgeon’s ability to best determine resection margins during prostatectomy. We performed desorption electrospray ionization mass spectrometry imaging (DESI-MSI) on 54 banked human cancerous and normal prostate tissue specimens to investigate the spatial distribution of a wide variety of small metabolites, carbohydrates, and lipids. In contrast to several previous studies, our method included Krebs cycle intermediates (m/z <200), which we found to be highly informative in distinguishing cancer from benign tissue. Malignant prostate cells showed marked metabolic derangements compared with their benign counterparts. Using the “Least absolute shrinkage and selection operator” (Lasso), we analyzed all metabolites from the DESI-MS data and identified parsimonious sets of metabolic profiles for distinguishing between cancer and normal tissue. In an independent set of samples, we could use these models to classify prostate cancer from benign specimens with nearly 90% accuracy per patient. Based on previous work in prostate cancer showing that glucose levels are high while citrate is low, we found that measurement of the glucose/citrate ion signal ratio accurately predicted cancer when this ratio exceeds 1.0 and normal prostate when the ratio is less than 0.5. After brief tissue preparation, the glucose/citrate ratio can be recorded on a tissue sample in 1 min or less, which is in sharp contrast to the 20 min or more required by histopathological examination of frozen tissue specimens.

[1]  Z. Hall Cancer , 1906, The Hospital.

[2]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  R. Tibshirani Regression Shrinkage and Selection via the Lasso , 1996 .

[4]  R. Tibshirani The lasso method for variable selection in the Cox model. , 1997, Statistics in medicine.

[5]  P. Narayan,et al.  Citrate in the diagnosis of prostate cancer , 1999, The Prostate.

[6]  R. Franklin,et al.  The Intermediary Metabolism of the Prostate: A Key to Understanding the Pathogenesis and Progression of Prostate Malignancy , 2000, Oncology.

[7]  A. Luini,et al.  Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  Richard M Caprioli,et al.  Mass spectrometric profiling of intact biological tissue by using desorption electrospray ionization. , 2005, Angewandte Chemie.

[9]  Michael J. Phelps,et al.  Specimen radiography in confirmation of MRI-guided needle localization and surgical excision of breast lesions. , 2006, AJR. American journal of roentgenology.

[10]  R. Franklin,et al.  The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots , 2006, Molecular Cancer.

[11]  T. Breslin,et al.  In vivo Margin Assessment During Partial Mastectomy Breast Surgery Using Raman Spectroscopy , 2007 .

[12]  R. Franklin,et al.  Zinc as an anti-tumor agent in prostate cancer and in other cancers. , 2007, Archives of biochemistry and biophysics.

[13]  R. Tibshirani,et al.  The Impact of Tumor Volume on Outcomes after Radical Prostatectomy: Implications for Prostate Cancer Screening , 2008 .

[14]  B. Guillonneau,et al.  Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. , 2009, European urology.

[15]  Freddy T. Nguyen,et al.  Intraoperative evaluation of breast tumor margins with optical coherence tomography. , 2009, Cancer research.

[16]  Liang Cheng,et al.  Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry. , 2010, Analytical chemistry.

[17]  G. Dakubo The Warburg Phenomenon and Other Metabolic Alterations of Cancer Cells , 2010 .

[18]  A. Levine,et al.  The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.

[19]  R. Cooks,et al.  Desorption electrospray ionization mass spectrometry for lipid characterization and biological tissue imaging. , 2011, Biochimica et biophysica acta.

[20]  Liang Cheng,et al.  Nondestructive, Histologically Compatible Tissue Imaging by Desorption Electrospray Ionization Mass Spectrometry , 2011, Chembiochem : a European journal of chemical biology.

[21]  L. Neumayer,et al.  High-frequency ultrasound for intraoperative margin assessments in breast conservation surgery: a feasibility study , 2011, BMC Cancer.

[22]  K. Ligon,et al.  Classifying human brain tumors by lipid imaging with mass spectrometry. , 2012, Cancer research.

[23]  R. Vessella,et al.  Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells , 2012, Clinical Cancer Research.

[24]  Shibdas Banerjee,et al.  Electrospray Ionization Mass Spectrometry: A Technique to Access the Information beyond the Molecular Weight of the Analyte , 2011, International journal of analytical chemistry.

[25]  Markus Graefen,et al.  Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. , 2012, European urology.

[26]  Prostate cancer: 'Galectin signature' reveals gal-1 as key player in angiogenesis , 2012, Nature Reviews Urology.

[27]  Trevor Hastie,et al.  An Introduction to Statistical Learning , 2013, Springer Texts in Statistics.

[28]  J. Joseph,et al.  Role of frozen section analysis of surgical margins during robot-assisted laparoscopic radical prostatectomy: a 2608-case experience. , 2013, Human pathology.

[29]  J. Brooks Managing localized prostate cancer in the era of prostate‐specific antigen screening , 2013, Cancer.

[30]  Daoyu Hu,et al.  Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint. , 2013, Quantitative imaging in medicine and surgery.

[31]  J. Engh,et al.  Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. , 2013, Neurosurgery.

[32]  R. Zare,et al.  Characterization of MYC-induced tumorigenesis by in situ lipid profiling. , 2013, Analytical chemistry.

[33]  J. Brooks Epigenetic changes in histologically normal prostate tissues. , 2013, The Journal of urology.

[34]  Trevor Hastie,et al.  Linear Model Selection and Regularization , 2021, Springer Texts in Statistics.

[35]  Peng Lee,et al.  Lipid metabolism in prostate cancer. , 2014, American journal of clinical and experimental urology.

[36]  Isaiah Norton,et al.  Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis , 2014, Proceedings of the National Academy of Sciences.

[37]  C. Muñoz-Pinedo,et al.  Regulation of cancer metabolism by oncogenes and tumor suppressors. , 2014, Methods in enzymology.

[38]  L. Eberlin DESI-MS imaging of lipids and metabolites from biological samples. , 2014, Methods in molecular biology.

[39]  F. Lecouvet,et al.  MRI-Based Assessment of Safe Margins in Tumor Surgery , 2014, Sarcoma.

[40]  R. Tibshirani,et al.  Alteration of the lipid profile in lymphomas induced by MYC overexpression , 2014, Proceedings of the National Academy of Sciences.

[41]  R. Tibshirani,et al.  Molecular assessment of surgical-resection margins of gastric cancer by mass-spectrometric imaging , 2014, Proceedings of the National Academy of Sciences.

[42]  J. Eastham,et al.  Significance and management of positive surgical margins at the time of radical prostatectomy , 2014, Indian journal of urology : IJU : journal of the Urological Society of India.

[43]  S. Singhal,et al.  Quantification of tumor fluorescence during intraoperative optical cancer imaging , 2015, Scientific Reports.

[44]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[45]  John T. Wei,et al.  Quantifying Gleason scores with photoacoustic spectral analysis: feasibility study with human tissues. , 2015, Biomedical optics express.

[46]  G. Giannico,et al.  Frozen section evaluation of margins in radical prostatectomy specimens: a contemporary study and literature review. , 2016, Annals of diagnostic pathology.

[47]  R. Tibshirani,et al.  Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging , 2016, PLoS medicine.